Clinical trial / 2013
Moderate daily flaxseed consumption improved glycemic control and insulin sensitivity in pre-diabetes
In a randomized crossover trial of 25 overweight or obese adults with pre-diabetes, participants ingested 0, 13, or 26 g of ground flaxseed daily for 12 weeks. Fasting glucose, insulin, and HOMA-IR significantly dropped during the 13 g intervention relative to control, whereas the 26 g dose showed no significant reductions. Levels of fructosamine, adiponectin, C-reactive protein, and interleukin-6 were unaltered across all phases.
- Study type
- Randomized crossover trial
- Who was studied
- 25 overweight or obese adults with pre-diabetes
- What was measured
- Fasting glucose, insulin, HOMA-IR, and inflammatory markers
THE PAPER
Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study.
Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE. Nutr Res, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.